Table of Contents United States Canavan Disease Therapeutics Market Report 2017 1 Canavan Disease Therapeutics Overview 1.1 Product Overview and Scope of Canavan Disease Therapeutics 1.2 Classification of Canavan Disease Therapeutics by Product Category 1.2.1 United States Canavan Disease Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Canavan Disease Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 Gene Therapy 1.2.4 Recombinant Enzyme 1.2.5 TUR-007 1.2.6 Others 1.3 United States Canavan Disease Therapeutics Market by Application/End Users 1.3.1 United States Canavan Disease Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 United States Canavan Disease Therapeutics Market by Region 1.4.1 United States Canavan Disease Therapeutics Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Canavan Disease Therapeutics Status and Prospect (2012-2022) 1.4.3 Southwest Canavan Disease Therapeutics Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Canavan Disease Therapeutics Status and Prospect (2012-2022) 1.4.5 New England Canavan Disease Therapeutics Status and Prospect (2012-2022) 1.4.6 The South Canavan Disease Therapeutics Status and Prospect (2012-2022) 1.4.7 The Midwest Canavan Disease Therapeutics Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Canavan Disease Therapeutics (2012-2022) 1.5.1 United States Canavan Disease Therapeutics Sales and Growth Rate (2012-2022) 1.5.2 United States Canavan Disease Therapeutics Revenue and Growth Rate (2012-2022) 2 United States Canavan Disease Therapeutics Market Competition by Players/Suppliers 2.1 United States Canavan Disease Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Canavan Disease Therapeutics Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Canavan Disease Therapeutics Average Price by Players/Suppliers (2012-2017) 2.4 United States Canavan Disease Therapeutics Market Competitive Situation and Trends 2.4.1 United States Canavan Disease Therapeutics Market Concentration Rate 2.4.2 United States Canavan Disease Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Canavan Disease Therapeutics Manufacturing Base Distribution, Sales Area, Product Type 3 United States Canavan Disease Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Canavan Disease Therapeutics Sales and Market Share by Region (2012-2017) 3.2 United States Canavan Disease Therapeutics Revenue and Market Share by Region (2012-2017) 3.3 United States Canavan Disease Therapeutics Price by Region (2012-2017) 4 United States Canavan Disease Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017) 4.1 United States Canavan Disease Therapeutics Sales and Market Share by Type (Product Category) (2012-2017) 4.2 United States Canavan Disease Therapeutics Revenue and Market Share by Type (2012-2017) 4.3 United States Canavan Disease Therapeutics Price by Type (2012-2017) 4.4 United States Canavan Disease Therapeutics Sales Growth Rate by Type (2012-2017) 5 United States Canavan Disease Therapeutics Sales (Volume) by Application (2012-2017) 5.1 United States Canavan Disease Therapeutics Sales and Market Share by Application (2012-2017) 5.2 United States Canavan Disease Therapeutics Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States Canavan Disease Therapeutics Players/Suppliers Profiles and Sales Data 6.1 Pfizer Inc 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Canavan Disease Therapeutics Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Pfizer Inc Canavan Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Turing Pharmaceuticals AG 6.2.2 Canavan Disease Therapeutics Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Turing Pharmaceuticals AG Canavan Disease Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview ... 7 Canavan Disease Therapeutics Manufacturing Cost Analysis 7.1 Canavan Disease Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Canavan Disease Therapeutics 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Canavan Disease Therapeutics Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Canavan Disease Therapeutics Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Canavan Disease Therapeutics Market Size (Value and Volume) Forecast (2017-2022) 11.1 United States Canavan Disease Therapeutics Sales Volume, Revenue Forecast (2017-2022) 11.2 United States Canavan Disease Therapeutics Sales Volume Forecast by Type (2017-2022) 11.3 United States Canavan Disease Therapeutics Sales Volume Forecast by Application (2017-2022) 11.4 United States Canavan Disease Therapeutics Sales Volume Forecast by Region (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Canavan Disease Therapeutics Figure United States Canavan Disease Therapeutics Market Size (K Pcs) by Type (2012-2022) Figure United States Canavan Disease Therapeutics Sales Volume Market Share by Type (Product Category) in 2016 Figure Gene Therapy Product Picture Figure Recombinant Enzyme Product Picture Figure TUR-007 Product Picture Figure Others Product Picture Figure United States Canavan Disease Therapeutics Market Size (K Pcs) by Application (2012-2022) Figure United States Sales Market Share of Canavan Disease Therapeutics by Application in 2016 Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Others Examples Table Key Downstream Customer in Others Figure United States Canavan Disease Therapeutics Market Size (Million USD) by Region (2012-2022) Figure The West Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022) Figure Southwest Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022) Figure The Middle Atlantic Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022) Figure New England Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022) Figure The South of US Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022) Figure The Midwest Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Canavan Disease Therapeutics Sales (K Pcs) and Growth Rate (2012-2022) Figure United States Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Canavan Disease Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017) Table United States Canavan Disease Therapeutics Sales (K Pcs) of Key Players/Suppliers (2012-2017) Table United States Canavan Disease Therapeutics Sales Share by Players/Suppliers (2012-2017) Figure 2016 United States Canavan Disease Therapeutics Sales Share by Players/Suppliers Figure 2017 United States Canavan Disease Therapeutics Sales Share by Players/Suppliers Figure United States Canavan Disease Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017) Table United States Canavan Disease Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017) Table United States Canavan Disease Therapeutics Revenue Share by Players/Suppliers (2012-2017) Figure 2016 United States Canavan Disease Therapeutics Revenue Share by Players/Suppliers Figure 2017 United States Canavan Disease Therapeutics Revenue Share by Players/Suppliers Table United States Market Canavan Disease Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017) Figure United States Market Canavan Disease Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2016 Figure United States Canavan Disease Therapeutics Market Share of Top 3 Players/Suppliers Figure United States Canavan Disease Therapeutics Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Canavan Disease Therapeutics Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Canavan Disease Therapeutics Product Category Table United States Canavan Disease Therapeutics Sales (K Pcs) by Region (2012-2017) Table United States Canavan Disease Therapeutics Sales Share by Region (2012-2017) Figure United States Canavan Disease Therapeutics Sales Share by Region (2012-2017) Figure United States Canavan Disease Therapeutics Sales Market Share by Region in 2016 Table United States Canavan Disease Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017) Table United States Canavan Disease Therapeutics Revenue Share by Region (2012-2017) Figure United States Canavan Disease Therapeutics Revenue Market Share by Region (2012-2017) Figure United States Canavan Disease Therapeutics Revenue Market Share by Region in 2016 Table United States Canavan Disease Therapeutics Price (USD/Pcs) by Region (2012-2017) Table United States Canavan Disease Therapeutics Sales (K Pcs) by Type (2012-2017) Table United States Canavan Disease Therapeutics Sales Share by Type (2012-2017) Figure United States Canavan Disease Therapeutics Sales Share by Type (2012-2017) Figure United States Canavan Disease Therapeutics Sales Market Share by Type in 2016 Table United States Canavan Disease Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017) Table United States Canavan Disease Therapeutics Revenue Share by Type (2012-2017) Figure Revenue Market Share of Canavan Disease Therapeutics by Type (2012-2017) Figure Revenue Market Share of Canavan Disease Therapeutics by Type in 2016 Table United States Canavan Disease Therapeutics Price (USD/Pcs) by Types (2012-2017) Figure United States Canavan Disease Therapeutics Sales Growth Rate by Type (2012-2017) Table United States Canavan Disease Therapeutics Sales (K Pcs) by Application (2012-2017) Table United States Canavan Disease Therapeutics Sales Market Share by Application (2012-2017) Figure United States Canavan Disease Therapeutics Sales Market Share by Application (2012-2017) Figure United States Canavan Disease Therapeutics Sales Market Share by Application in 2016 Table United States Canavan Disease Therapeutics Sales Growth Rate by Application (2012-2017) Figure United States Canavan Disease Therapeutics Sales Growth Rate by Application (2012-2017) Table Pfizer Inc Basic Information List Table Pfizer Inc Canavan Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Pfizer Inc Canavan Disease Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer Inc Canavan Disease Therapeutics Sales Market Share in United States (2012-2017) Figure Pfizer Inc Canavan Disease Therapeutics Revenue Market Share in United States (2012-2017) Table Turing Pharmaceuticals AG Basic Information List Table Turing Pharmaceuticals AG Canavan Disease Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Turing Pharmaceuticals AG Canavan Disease Therapeutics Sales Growth Rate (2012-2017) Figure Turing Pharmaceuticals AG Canavan Disease Therapeutics Sales Market Share in United States (2012-2017) Figure Turing Pharmaceuticals AG Canavan Disease Therapeutics Revenue Market Share in United States (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Canavan Disease Therapeutics Figure Manufacturing Process Analysis of Canavan Disease Therapeutics Figure Canavan Disease Therapeutics Industrial Chain Analysis Table Raw Materials Sources of Canavan Disease Therapeutics Major Players/Suppliers in 2016 Table Major Buyers of Canavan Disease Therapeutics Table Distributors/Traders List Figure United States Canavan Disease Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022) Figure United States Canavan Disease Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure United States Canavan Disease Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022) Table United States Canavan Disease Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Canavan Disease Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Canavan Disease Therapeutics Sales Volume (K Pcs) Forecast by Type in 2022 Table United States Canavan Disease Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Canavan Disease Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Canavan Disease Therapeutics Sales Volume (K Pcs) Forecast by Application in 2022 Table United States Canavan Disease Therapeutics Sales Volume (K Pcs) Forecast by Region (2017-2022) Table United States Canavan Disease Therapeutics Sales Volume Share Forecast by Region (2017-2022) Figure United States Canavan Disease Therapeutics Sales Volume Share Forecast by Region (2017-2022) Figure United States Canavan Disease Therapeutics Sales Volume Share Forecast by Region in 2022 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources